American journal of obstetrics and gynecology
-
Destructive procedures to permit vaginal delivery of the fetus with hydrocephalus are rarely performed. ⋯ A reappraisal of the proper role of cephalocentesis in modern obstetrics is offered.
-
Am. J. Obstet. Gynecol. · Aug 2001
Scheduled cesarean delivery and the prevention of human immunodeficiency virus transmission: a survey of practicing obstetricians.
To characterize practice patterns among obstetrician-gynecologists with respect to delivery for human immunodeficiency virus (HIV)-seropositive women, following publication of the 1999 American College of Obstetricians and Gynecologists (ACOG) Committee Opinion regarding scheduled cesarean delivery for HIV-infected patients. ⋯ There is considerable disagreement among practicing obstetricians with respect to the 1999 ACOG Committee Opinion recommendation to offer cesarean delivery to all HIV-seropositive women. Most physicians use viral load detection to assist with the counseling in delivery options for HIV-infected pregnant women.
-
Am. J. Obstet. Gynecol. · Jul 2001
Randomized Controlled Trial Clinical TrialA randomized controlled trial of fentanyl for abortion pain.
Our aim was to find out whether intravenous fentanyl was effective in reducing the pain of first-trimester abortion. ⋯ Fentanyl, when compared with the placebo, reduced abortion pain by 1.0 point on an 11-point scale. This reduction was of questionable clinical significance and was less than desired by the women included in the study.
-
Am. J. Obstet. Gynecol. · Jul 2001
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.
Among women diagnosed with pelvic inflammatory disease, we examined the associations between hormonal or barrier methods of contraception and upper genital tract infection or inflammation. ⋯ No hormonal or barrier contraceptive method was related to a reduction in upper genital tract disease among women with clinical pelvic inflammatory diseases.
-
Am. J. Obstet. Gynecol. · Jul 2001
Comparative StudyHeparin-induced thrombocytopenia is rare in pregnancy.
The indications for heparin use during pregnancy are expanding; however, heparin is associated with serious adverse effects including heparin-induced thrombocytopenia. Low-molecular-weight heparin is expensive but is associated with less frequent occurrences of heparin-induced thrombocytopenia in the nonpregnant population. However, the incidence of heparin-induced thrombocytopenia during pregnancy is unknown. The purpose of this study was to compare the incidence of heparin-induced thrombocytopenia in pregnant and nonpregnant women. ⋯ Heparin-induced thrombocytopenia is extremely rare in pregnant women.